|
시장보고서
상품코드
2055319
감염 감시 솔루션 시장 : 제품 및 서비스별, 감염증 유형별, 최종사용자별, 지역별Infection Surveillance Solutions Market, by Product and Services, by Infection Type by End User and By Geography |
||||||
감염 감시 솔루션 시장은 2026년 10억 2,040만 달러로 추정되며, 2033년까지 26억 1,680만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 14.4%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 10억 2,040만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 14.40% | 2033년 시장 규모 예측 : | 26억 1,680만 달러 |
감염 감시 솔루션이란 병원 등 의료 기관이 환자 관련 데이터를 주 및 연방 당국에 보고할 수 있도록 지원하는 소프트웨어입니다. 감염 감시 솔루션은 의료 업계에서 병원 내 감염 관련 데이터를 수집하고, 감염 양상을 조사하며, 지역사회로의 감염 확산을 억제하기 위해 활용되고 있습니다. 병원 내 감염이란 병원이나 의료시설에서 사람들에게 감염이 확산되는 것을 말합니다. 이 소프트웨어는 감염이 발생할 경우 병원의 IP 주소로 경보를 전송하여, HAI 전문가와 간호사가 감염 환자를 치료할 수 있도록 함으로써 집단 감염을 예방하는 역할을 합니다. 감염 감시 솔루션은 의료시설 내 의료 관련 감염(HAI)을 효과적으로 관리할 수 있도록 지원하는 프로그램입니다. 폐렴, 위장 질환, 요로 감염, 원발성 혈류 감염 및 일부 수술과 관련된 감염은 주요 병원 내 감염(HAI)의 일부입니다. 병원 내 감염(HAI)의 높은 발생률은 전 세계 정부들에게 큰 우려 사항이며, 이에 따라 각 정부는 HAI를 효과적으로 관리하고 발생률을 낮추기 위한 정책을 수립하고 있습니다.
시장 역학
시장의 주요 기업들이 제품 포트폴리오 확대를 목적으로 한 인수합병 등 비유기적 성장 전략을 채택하는 사례가 증가하고 있는 점이, 예측 기간 동안 시장 성장을 견인할 것으로 예측됩니다. 예를 들어, 2019년 5월, 소프트웨어 기업 RLDatix는 다양한 업종을 대상으로 하는 클라우드 기반 계약·규정 준수·수익 관리 소프트웨어를 제공하는 iContracts를 인수했다고 발표했습니다. 이번 인수를 통해 RLDatix의 환자 안전 플랫폼과 iContracts의 최첨단 정책 관리 기능이 통합됨에 따라, 조직은 역동적인 정책 및 절차의 실행을 통해 사고의 근본 원인을 해결할 수 있게 되었습니다.
본 조사의 주요 특징
- 본 조사에서는 다양한 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표(기업 개요, 제품 포트폴리오, 주요 성과, 재무 실적, 전략)를 바탕으로 전 세계 감염병 감시 솔루션 시장의 주요 기업 프로파일을 작성하였습니다.
- 본 보고서의 인사이트를 바탕으로, 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대 및 마케팅 전략에 관해 정보에 입각한 의사결정을 내릴 수 있게 됩니다.
- 본 세계의 감염병 감시 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자 여러분은 전 세계 감염병 감시 솔루션 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 감염 감시 솔루션 시장 : 2021년-2033년
제5장 세계의 감염 감시 솔루션 시장 : 감염증 유형별, 2021년-2033년
제6장 세계의 감염 감시 솔루션 시장 : 최종사용자별, 2021년-2033년
제7장 세계의 감염 감시 솔루션 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 섹션
LSH 26.06.23Infection Surveillance Solutions Market is estimated to be valued at USD 1020.4 Mn in 2026 and is expected to reach USD 2,616.8 Mn by 2033, growing at a compound annual growth rate (CAGR) of 14.4% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 1020.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 14.40% | 2033 Value Projection: | USD 2,616.8 Mn |
Infection surveillance solution is software that helps healthcare facilities such as hospitals and others to report data related to patients, to the state and federal authorities. Infection surveillance solutions are used in the healthcare industry to collect data on nosocomial infections to study the pattern of infections and regulate their spread in the community. Nosocomial infections are infections that are spread to people from hospitals or healthcare centers. This software alerts hospital Internet Protocol (IPs) in case of infection occurrence so that HAI specialists and nurses can treat patients suffering from the infection in order to avoid outbreaks of infection. Infection surveillance solutions are programs, which help in the effective management of the Healthcare-Acquired Infections (HAIs) in healthcare facilities. Pneumonia, gastrointestinal illness, urinary tract infections, primary bloodstream infections, and infections related to some surgery are the few major Healthcare-Acquired Infections (HAIs). High incidences of Healthcare-Acquired Infections (HAIs) is a major concern for government across the globe, and hence, various governments have outlined policies to effectively manage and reduce incidences of HAIs.
Market Dynamics
Increasing adoption of inorganic growth strategies, such as acquisitions by key players in the market to expand their product portfolio, is expected to drive the market growth over the forecast period. For instance, in May 2019, RLDatix, a software company, announced that they had acquired iContracts, a provider of cloud-based contract, compliance, and revenue management software for multiple industries. The acquisition brings together the RLDatix patient safety platform with iContracts leading policy management capabilities to allow organizations, for the first time, to take action on the root causes of incidents through the implementation of policies and procedures that are dynamic.
Key features of the study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global infection surveillance solutions market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study are Baxter, BD, STERIS, Getinge AB, Medtronic, Koninklijke Philips N.V., Abbott, Medexter Healthcare, Asolva, GOJO Industries, Inc., Wolters Kluwer N.V., VigiLanz Corporation, RLDatix, Roper Technologies Inc., Health Outcomes Worldwide, OpGen, Inc., Urovant Sciences, and Premier
- Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global infection surveillance market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global infection surveillance solutions market
Market Segmentation
- Global Infection Surveillance Solutions Market, By Products and Services (Revenue, USD Mn, 2021 - 2033)
- Software
- On-Premises
- Web-Based
- Services
- Support & Maintenance
- Training & Consulting
- Global Infection Surveillance Solutions Market, By Infection Type (Revenue, USD Mn, 2021 - 2033)
- Surgical Site Infections
- Blood Stream Infections
- Urinary Tract Infections
- Global Infection Surveillance Solutions Market, By End User (Revenue, USD Mn, 2021 - 2033)
- Hospitals
- Clinics
- Ambulatory Surgical Centers
- Other (Specialty Center, etc.)
- Global Infection Surveillance Market, By Region (Revenue, USD Mn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Company Profiles
- Baxter
- BD
- STERIS
- Getinge AB
- Medtronic
- Koninklijke Philips N.V.
- Abbott
- Medexter Healthcare
- Asolva
- GOJO Industries, Inc.
- Wolters Kluwer N.V.
- VigiLanz Corporation
- RLDatix
- Roper Technologies, Inc.
- Health Outcomes Worldwide
- OpGen, Inc.
- Urovant Sciences
- Premier
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Products and Services
- Market Snapshot, By Infection Type
- Market Snapshot, By End User
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product Launch
- Technological Advancements
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions
4. Global Infection Surveillance Solutions Market, By 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Software
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- On-Premises
- Web-Based
- Services
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Support & Maintenance
- Training & Consulting
5. Global Infection Surveillance Solutions Market, By Infection Type, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Surgical Site Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Blood Stream Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Urinary Tract Infections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
6. Global Infection Surveillance Solutions Market, By End User, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segments Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Ambulatory Surgical Center
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
- Others (Specialty Center, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021-2033, (US$ Million)
7. Global Infection Surveillance Solutions Market, By Region, 2021 - 2033, (US$ Million)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (US$ Million)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Products and Services, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Infection Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (US$ Million)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Baxter
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BD
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- STERIS
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Getinge AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medtronic
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Koninklijke Philips N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Medexter Healthcare
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Asolva
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- GOJO Industries, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Wolters Kluwer N.V.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- VigiLanz Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- RLDatix
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Roper Technologies, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Health Outcomes Worldwide
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- OpGen, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Urovant Sciences
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Premier
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
9. Section
- Research Methodology
- About Us
